TINAVI
Beijing Tinavi Medical Technologies Co., Ltd. is a publicly listed (SSE 688277) Chinese designer and manufacturer of orthopedic surgical robotic systems, including TiRobot and TiRobot II, serving 200+ hospitals across China with expanding access to North America and Europe via CSA and CE MDR certifications.
- Company typePublic
- Founded2005
- HeadquartersBeijing, China
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What TINAVI does
Beijing Tinavi Medical Technologies Co., Ltd. (TINAVI) is a Beijing-headquartered, publicly listed (SSE STAR Market, Code 688277, IPO date July 7, 2020) designer, manufacturer, and commercializer of orthopedic surgical robotic systems, founded in 2005 and operating for 19 years with a workforce of 101–250. Its core platform, the TiRobot family, integrates a six-axis robotic arm, an optical tracking system, and a main control surgical cart, and is reportedly the world's only orthopedic robot capable of performing spine, joint, and trauma procedures on a single device, with quoted clinical accuracy of 1 mm, radiation exposure reduction of about 70%, and surgical efficiency improvement of about 30%. The lineup includes the original TiRobot (launched 2016), TiRobot II (launched April 2021), TiRobot Recon (a total knee arthroplasty robot in NMPA innovative-device review since November 2020), a 5G Remote Surgery System, and bundled disposable instrument toolkits, plus the co-developed Viper Prime™&TiRobot integrated solution with Johnson & Johnson Medical.
TINAVI monetizes through high-value capital equipment sales to hospitals, recurring revenue from disposable precision tracking components and procedure-specific toolkits, and clinical training and maintenance services delivered through a direct enterprise sales force, supplemented by a strategic co-development and distribution partnership with Johnson & Johnson Medical signed in October 2019. The customer base consists of major tertiary hospitals and orthopedic surgery centers in China; the TiRobot system is deployed in 200+ medical institutions across 31 provincial-level regions and has supported 150,000+ cumulative surgeries as of Q1 2025. Distribution also reaches North America via CSA certification (December 2021) and the EU via CE MDR certification (August 2024), and a Robot Application Training Center network across hospitals including Renji, Qilu, Beijing Jishuitan, Anhui Medical University, and China Medical University supports surgeon enablement.
Beyond products, TINAVI operates a wholly-owned subsidiary, Beijing Medical Robot Industry Innovation Center, and jointly runs the Joint Intelligent Orthopaedic Lab with Beijing Jishuitan Hospital and the Beijing Orthopedic Robotic System Engineering Research Center with Beijing's municipal development authorities. Reimbursement coverage under Beijing Class A Medical Insurance (effective October 23, 2021) materially expands addressable demand within China. The company is led by Chairman Zhang Songgen and CEO Dr. Xu Jin, and has received national, regional, and international recognition including the Second Prize of the National Science and Technology Progress Award (2015) and coverage in Nature's special issue on medical robotics in China.
TINAVI firmographics
Firmographics- Name
- TINAVI
- Legal name
- Beijing Tinavi Medical Technologies Co., Ltd.
- Website
- https://en.tinavi.com
- Company type
- Public
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Beijing Tinavi Medical Technologies Co., Ltd. is a publicly listed (SSE 688277) Chinese designer and manufacturer of orthopedic surgical robotic systems, including TiRobot and TiRobot II, serving 200+ hospitals across China with expanding access to North America and Europe via CSA and CE MDR certifications.
- Ownership category
- akta.pro rank
TINAVI industry classification
Industry- Product category
- Orthopedic Surgical Robotics
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Healthcare & Assistive Robotics (HDAAAIAC), Orthopedics & Sports Medicine Telemedicine Platforms (HLALAGAO)
Keywords
Where TINAVI is headquartered
LocationHeadquarters
- HQ city
- Beijing
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
TINAVI business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Orthopedic Surgical Robot Systems: Sale of TiRobot orthopedic surgical robot systems to hospitals and medical institutions. Systems include robotic arm, optical tracking system, and main control surgical cart components along with compatible instruments.
- Disposable and Optional Toolkits: Sale of disposable precision tracking components, locating toolkits for various orthopedic procedures (spine, trauma, hand surgery, cervical surgery, hip surgery, foot & ankle surgery).
- Clinical Support and Training Services: Surgery observation, training services, clinical support for newly installed robots, and maintenance services provided to collaborative hospitals.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
TINAVI product offering
Product offeringCore offering
TINAVI designs, manufactures, and sells orthopedic surgical robot systems (TiRobot family) and related disposable instruments for use in spine, trauma, and joint surgeries. The company sells its robotic platforms, including the TiRobot and TiRobot II systems, along with procedure-specific locating toolkits and complementary services such as clinical training, remote surgery platforms, and maintenance to hospitals and medical institutions.
Product overview
TINAVI offers a unified orthopedic robotic surgery platform centered on the TiRobot product family, including TiRobot II (latest generation, launched 2021) and TiRobot Orthopaedic Robotic System (original generation, launched 2016), both serving as the core surgical robot systems capable of spinal, trauma, and joint surgeries. The product portfolio also includes TiRobot Instruments (disposable and optional toolkits for specific surgical types), the 5G Remote Surgery System (remote consultation and tele-surgery platform), TiRobot Recon (total knee arthroplasty module), and Viper PrimeTM&TiRobot (joint integrated implant solution with Johnson & Johnson). All TiRobot systems share a common architecture combining optical tracking, robotic arm positioning, and main control surgical cart. TINAVI College provides the educational and training platform for surgeons using these systems.
Differentiator
Problem solved
Functional benefit
Brands
- TiRobot: Orthopedic robotic system for spinal and trauma surgery, featuring robotic arm, optical tracking system, and main control surgical cart for precise positioning.
- TiRobot II
- 5G Remote Surgery System
- TINAVI College
Products and services
- TiRobot Orthopaedic Robotic System (TiRobot®)
Quantifiable outcome
- Surgical accuracy reaches 1mm
- +4 more outcomes
Companies that use TINAVI
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
TINAVI technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability6 records
Feature6 records
TINAVI partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered minor, flagship and core.
- Shandong WeigaominorTINAVI and Shandong Weigao signed strategic agreement for orthopedic market collaboration.
- The First Hospital of China Medical UniversityflagshipJoint establishment of Robot Application Training Center for orthopedic robot training programs.
- Johnson & Johnson (Viper Prime)flagshipJoint development of Viper PrimeTM&TiRobot integrated surgical treatment combining TiRobot with J&J's Viper PrimeTM minimally invasive implant system for enhanced spinal surgery solutions.
- Tianjin HospitalflagshipStrategic cooperation agreement signed for robot surgery skills training courses.
- Fujian Provincial HospitalflagshipStrategic cooperation agreement signed for robot surgery skills training courses.
- Jiangsu Provincial HospitalflagshipStrategic cooperation agreement signed for robot surgery skills training courses.
- Beijing Jishuitan HospitalcoreJoint creation of Joint Intelligent Orthopaedic Lab with agreement including patent transfer, establishment of intelligent orthopaedics research fund and joint laboratory for orthopaedic surgical robot transformation.
- Beijing Municipal Development and Reform CommissioncoreJointly declared construction plan of Beijing Orthopedic Robotic System Engineering Research Center by Beijing Jishuitan Hospital, TINAVI and another medical company. Approved to operate as independent legal entity working as innovative platform driven by clinical requirements.
- The First Hospital of Anhui Medical UniversityflagshipJoint establishment of Robot Application Training Center where experts introduced clinical application of TiRobot in spine, trauma, limbs.
- Guangdong Provincial Hospital of Chinese Medicine (Zhuhai)coreOrthopaedic surgical robot project kicked off marking TiRobot settling in Zhuhai and being put into clinical application.
- Beijing Medical Robot Industry Innovation CentercoreTINAVI's holding subsidiary organizing 3rd International Forum on Innovation and Development of Medical Robot 2020. Strategic cooperation agreement signed with Chinese Society of Biomedical Engineering to build medical robot technology innovation cluster.
- Qilu Hospital of Shandong UniversityflagshipJoint establishment of Robot-assisted Spinal Surgery Training Center providing Preliminary and Advanced Robot-assisted Spinal Surgery Skills Training Programs for surgeons throughout the province and country.
- Beijing Jishuitan HospitalcoreOpened Joint Intelligent Orthopaedic Lab and signed agreement on transformation of orthopaedic surgical robot including patent transfer, intelligent orthopaedics research fund, and joint laboratory.
- Renji Hospital of Shanghai Jiaotong University School of MedicineflagshipStrategic cooperation for opening of Robot-assisted Spinal Surgery Skills Training Program and inauguration of Robot-assisted Spinal Surgery Clinical Technology Application Center at Showsite Center, strengthening advantages and surgical skills in eastern China.
- Johnson & Johnson MedicalcoreTINAVI and J&J signed agreement on joint R&D, cooperative marketing and distribution. Through this cooperation, TINAVI's surgical robots combined with J&J's orthopedic implants deliver superior digital surgical treatment solutions to Chinese patients and globally. The partnership also includes doctor training programs and joint robot-assisted spinal surgery skills training centers at major hospitals.
Scale indicators8 records
Recent moves7 records
Expansion highlights5 records
TINAVI competitors and assessment
Company assessmentBroad incumbents
- Intuitive Surgical: Intuitive Surgical's da Vinci platform dominates surgical robotics broadly (general surgery, urology, gynecology) and is the broad incumbent reference for any surgical robotics business. Comparable on robotic surgery platform economics, recurring instrument revenue, and surgeon-training-driven adoption, though not directly competing in orthopedics.
Direct peers
- Medtronic: Medtronic's Mazor robotic spine surgery platform (acquired from Mazor Robotics) is a direct competitor to TiRobot in spine surgical robotics. Both target hospitals with capital-equipment sales models and disposable instrument revenue streams.
- NuVasive: NuVasive's Pulse surgical automation and robotics platform competes in spine surgical robotics. Comparable business model focused on spine enabling-technology sales to hospitals with surgeon-training-driven adoption.
- Globus Medical: Globus Medical's ExcelsiusGPS robotic navigation platform competes directly with TiRobot in spine surgical robotics. Both emphasize real-time tracking, robotic arm positioning, and navigation in spine and trauma orthopedic procedures.
- Stryker: Stryker's Mako robotic-arm assisted surgery platform is the global market leader in orthopedic surgical robotics for knee, hip, and spine. Directly comparable to TINAVI's TiRobot as the dominant global incumbent competing for the same hospital orthopedic surgical robotics budgets.
- Johnson & Johnson (DePuy Synthes / Velys): J&J's Velys robotic-assisted surgery platform for knee and integrated Viper Prime™&TiRobot partnership make J&J both a partner and a competitor. Comparable as a strategic orthopedic implant + robotics bundling competitor targeting the same Chinese and global hospital customers.
- Smith+Nephew: Smith+Nephew's CORI handheld robotic-assisted surgical system for knee arthroplasty competes directly with TiRobot Recon. Both target orthopedic procedure robotics with handheld/portable form factors, though TINAVI's full-platform approach extends beyond knee.
Emerging players
- Brainlab: Brainlab provides surgical navigation, planning, and mixed-reality surgical platforms with growing robotics exposure (e.g., Loop-X). Comparable in surgical navigation and image-guided orthopedic workflows as an emerging technology competitor.
- Renishaw: Renishaw's Neuromate and neurosurgical robot platforms represent an emerging player in surgical robotics with overlap on the technology side (precision robotic positioning, navigation). Less direct overlap with TINAVI as Neuromate is neurosurgical rather than orthopedic.
Regional players
- MicroPort (Shanghai MicroPort MedBot): MicroPort's MedBot develops surgical robotics including orthopedic applications (e.g., Honghu, Jianzhong). Comparable as a Chinese-listed domestic competitor in surgical robotics, though TINAVI's orthopedic focus and 19-year orthopedic track record differentiate it from MedBot's broader specialty mix.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
TINAVI social profiles
Digital presenceTINAVI compliance and trust
Trust signalCompliance5 records
TINAVI financial estimates
Financial estimateRevenue estimate
Valuation estimate
TINAVI leadership team
Management profileNumber of profiles
Profiles2 records
TINAVI subsidiaries and ownership
Company hierarchySubsidiaries1 record
TINAVI funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TINAVI M&A and investment
M&A and investmentM&A
Investments3 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TINAVI
What does TINAVI do?
TINAVI designs, manufactures, and sells orthopedic surgical robot systems (TiRobot family) and related disposable instruments for use in spine, trauma, and joint surgeries. The company sells its robotic platforms, including the TiRobot and TiRobot II systems, along with procedure-specific locating toolkits and complementary services such as clinical training, remote surgery platforms, and maintenance to hospitals and medical institutions.
Is TINAVI a public or private company?
TINAVI is a public company. It is classified as public and is currently operating.
When was TINAVI founded?
TINAVI was founded in 2005. It employs 11 to 50 people.
Where is TINAVI based?
TINAVI is headquartered in Beijing, China, in the Asia region.
How does TINAVI make money?
Three revenue lines are on record. Orthopedic Surgical Robot Systems are the primary driver. The others are disposable and Optional Toolkits and clinical Support and Training Services.
Who are TINAVI's main competitors?
Intuitive Surgical is listed as a broad incumbent. Direct peers are Medtronic, NuVasive, Globus Medical, Stryker, Johnson & Johnson (DePuy Synthes / Velys) and Smith+Nephew. Emerging players are Brainlab and Renishaw. MicroPort (Shanghai MicroPort MedBot) is listed as a regional player.
Does TINAVI have an API?
No public API is recorded for TINAVI.
What industry is TINAVI in?
TINAVI's product category is Orthopedic Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339112 and its SIC code is 3842.